Targeting the mechanisms of progression in castration-resistant prostate cancer

Eur Urol. 2015 Mar;67(3):480-1. doi: 10.1016/j.eururo.2014.11.024. Epub 2014 Nov 21.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Androgen Antagonists / therapeutic use*
  • Animals
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Drug Resistance, Neoplasm*
  • Humans
  • Male
  • Prostatic Neoplasms, Castration-Resistant / drug therapy*

Substances

  • Androgen Antagonists
  • Antineoplastic Agents, Hormonal